Middle Branch Partners thrilled to welcome Winfried Schaller, former CEO of Lincotek Group, to our Board of Advisors.

Middle Branch Partners initiated this deal, and advised Lenkbar LLC (US) during their agreement to be acquired by Intech, a global MedTech manufacturer and portfolio company of Montagu Private Equity of London, UK.

Middle Branch Partners initiated this deal, and advised our client Acrotec Group, a portfolio company of The Carlyle Group, during its agreement to acquire Axial Medical, a precision MedTech manufacturer in Warminster Pennsylvania.

Middle Branch Partners sourced and advised our clients Mycoscience and Ethide Laboratories as they were acquired by Millstone Medical Outsourcing, the industry's leading partner of choice for medical manufacturers' post-manufacturing and aftermarket services.

Our client UFP Technologies has acquired Advant Medical Molding in a non-auction, private transaction. Read more here.

Some consider trade shows to be a necessary evil — be seen or be gone. Others see them as a great tool in their marketing kit. They are a really a combination of both. As we re-enter a more customary world of MedTech tradeshows and events, it may be useful to look at why we attend them in the first place.

An interview with our partners Larry Barr, Göran Brorsson, and Chuck Weikel discussing the first half of 2021 in the MedTech M&A markets.

For years we have always thought the best technical reference for the MedTech metals industry is the Orthomaterials Pocketbook put out by our friends at Forécru. With contributions by leading companies across the industry, it has much detail about the processes used and details that even non-engineers can understand.

Panelists Laurence Barr, Founding Partner at Middle Branch Partners; David Anderson, Managing Director at Capital One Healthcare; Marie Lotto, Senior Director of M&A Integration at Hologic; and moderator Charles Weikel, Founding Partner at Middle Branch Partners had a great conversation about the state of MedTech M&A markets and finance during late-COVID. If you couldn't attend the webinar, or want to revisit portions of the conversation, you may now view the archived video on YouTube.

Middle Branch Partners and Capital One are pleased to present the first in a series of webinars on MedTech, banking, and the state of mergers and acquisitions in 2021 and beyond. Speakers include: Laurence Barr, Founding Partner at Middle Branch Partners; David Anderson, Managing Director at Capital One Healthcare; and Marie Lotto, Senior Director of M&A Integration at Hologic.

Early earnings previews from companies reinforce Orthoworld’s belief that the orthopedic market will decline around -10% in 2020. Below they preview some positives from the fourth quarter and the most recent COVID and U.S. jobs data, as well as some early thoughts for 2021.

Content republished with permission from ORTHOWORLD® Inc.

Our partners Larry Barr, Göran Brorsson, and Chuck Weikel sat down to discuss the state of MedTech M&A and expectations for the new year.

There is no question that there is larger distance between European markets today and anytime in recent memory. This had begun before Covid-19 with protectionist trade policies and then continued up to today, as travel restrictions and limitations on visits and shut down much M/A activity, both in Europe and North America. To understand this in greater detail, Chuck Weikel discussed with Göran Brorsson, our European Partner at Middle Branch Partners, about what he is experiencing in the European market.

It is an exciting time for us and we will be at shows around the world and industry. We look forward to getting caught up with you there.